Matteo Balzarro1, Emanuele Rubilotta2, Vito Mancini3, Maurizio Serati4, Marilena Gubbiotti5, Andrea Braga6, Omar Saleh7, Marco Torrazzina8, Ewelina Malanowska9, Sergio Serni10, Giuseppe Carrieri3, Alessandro Antonelli2, Vincenzo Li Marzi10. 1. Department of Urology, Azienda Ospedaliero Universitaria of Verona, University of Verona, Piazzale Stefani n1, 37126 Verona, Italy. 2. Department of Urology, Azienda Ospedaliero Universitaria of Verona, University of Verona, Verona, Italy. 3. Section of Urology and Renal Transplantation, University of Foggia, Policlinico di Foggia, Foggia, Italy. 4. Department of Obstetrics and Gynecology, Del Ponte Hospital, University of Insubria, Varese, Italy. 5. Department of Urology, San Donato Hospital, Arezzo, Italy. 6. Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Mendrisio, Switzerland. 7. Department of Surgery, Urology, Morgagni Pierantoni Hospital, Forli, Italy. 8. Unità Operativa Complessa of Obstetrics and Gynecology, Magalini Hospital, Villafranca di Verona, Italy. 9. Department of Gynaecology, Endocrinology and Gynaecologic Oncology, Pomeranian Medical University, Szczecin, Poland. 10. Unit of Minimally Invasive, Robotic Urologic Surgery and Kidney Transplantation, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
Abstract
AIM: To assess the prevalence of anterior vaginal wall dehiscence in women who underwent anterior vaginal wall colpotomy for pelvic organ prolapse or stress urinary incontinence and to evaluate the influence of suture materials and techniques on wound dehiscence. MATERIALS AND METHODS: This multicenter, prospective study enrolled naïve women for urogynecological surgery affected by anterior vaginal wall defect or stress urinary incontinence. Performed surgical procedures were anterior vaginal wall repair (AVWR) with native tissue (N-AVWR) or polypropylene mesh (M-AVWR), trans-obturator polypropylene in-out middle urethral sling (MUS). Used suture materials were Vicryl 2-0, Vicryl Rapide 2-0, and Monocryl 3-0. Suture techniques were running interlocking or interrupted. Follow-up was performed daily during hospitalization and in outpatient clinic after 10-14, 30 days, and after 3 months. RESULTS: A total of 1139 patients were enrolled. AVWR were 790: 89.1% N-AVWR, and 10.9% M-AVWR. Polypropylene MUS were 349. Women with prosthetic implantation were 38.2%, while 61.8% had native tissue repair. Overall Vicryl was used in 53.9%, Vicryl Rapide in 37.4%, and Monocryl in 8.7%. Overall running interlocking sutures were 66.5%, while interrupted were 33.5%. Overall wound dehiscence prevalence was 0.9% (10/1139). Wound dehiscence rate of 0.6% (5/790) was documented in AVWR: 0.3% (2/704) in N-AVWR, and 3.5% (3/86) in M-AVWR. Among women underwent MUS, 1.4% (5/349) showed wound dehiscence. In patients who underwent prosthetic surgery, the overall dehiscence prevalence was 1.8% (8/435). A statistically significant higher rate of wound dehiscence was found in women with implanted prosthetic materials. DISCUSSION: We reported for the first time the prevalence of wound dehiscence in females who underwent colpotomy for AVWR or MUS. Wound dehiscence occurrence was low, but non-negligible. We found that this complication was poorly associated to the suture methods and materials, while prosthetic material represented a risk factor for wound healing.
AIM: To assess the prevalence of anterior vaginal wall dehiscence in women who underwent anterior vaginal wall colpotomy for pelvic organ prolapse or stress urinary incontinence and to evaluate the influence of suture materials and techniques on wound dehiscence. MATERIALS AND METHODS: This multicenter, prospective study enrolled naïve women for urogynecological surgery affected by anterior vaginal wall defect or stress urinary incontinence. Performed surgical procedures were anterior vaginal wall repair (AVWR) with native tissue (N-AVWR) or polypropylene mesh (M-AVWR), trans-obturator polypropylene in-out middle urethral sling (MUS). Used suture materials were Vicryl 2-0, Vicryl Rapide 2-0, and Monocryl 3-0. Suture techniques were running interlocking or interrupted. Follow-up was performed daily during hospitalization and in outpatient clinic after 10-14, 30 days, and after 3 months. RESULTS: A total of 1139 patients were enrolled. AVWR were 790: 89.1% N-AVWR, and 10.9% M-AVWR. Polypropylene MUS were 349. Women with prosthetic implantation were 38.2%, while 61.8% had native tissue repair. Overall Vicryl was used in 53.9%, Vicryl Rapide in 37.4%, and Monocryl in 8.7%. Overall running interlocking sutures were 66.5%, while interrupted were 33.5%. Overall wound dehiscence prevalence was 0.9% (10/1139). Wound dehiscence rate of 0.6% (5/790) was documented in AVWR: 0.3% (2/704) in N-AVWR, and 3.5% (3/86) in M-AVWR. Among women underwent MUS, 1.4% (5/349) showed wound dehiscence. In patients who underwent prosthetic surgery, the overall dehiscence prevalence was 1.8% (8/435). A statistically significant higher rate of wound dehiscence was found in women with implanted prosthetic materials. DISCUSSION: We reported for the first time the prevalence of wound dehiscence in females who underwent colpotomy for AVWR or MUS. Wound dehiscence occurrence was low, but non-negligible. We found that this complication was poorly associated to the suture methods and materials, while prosthetic material represented a risk factor for wound healing.
Anterior vaginal wall repair (AVWR) and the positioning of middle urethral sling
(MUS) are the most performed urogynecological procedures worldwide.[1,2] These procedures have a low
complication rate. However, when prosthetic material is used, exposure is the most
reported complication with a rate of up to 14% in MUS, and up to 17% in cystocele
repair.[3-5]Surgical wound dehiscence may affect any surgical procedure, and it is defined as the
separation of opposed or sutured margins.[6-9] This complication usually
occurs between 7 and 14 days after surgery.[8,9] Prevalence of anterior
colpotomy dehiscence has never been investigated, and data are available only
regarding wound dehiscence after transvaginal hysterectomy.[10-12] Wound dehiscence is an early
complication, usually associated to symptoms. However, in case of asymptomatic short
wound dehiscence, the early diagnosis of this complication may be missed. In
patients who underwent prosthetic surgery, the underlying misleading diagnosis of
wound dehiscence may be the first step leading to mesh/tape exposure, that is,
usually a late complication. Due to the lack of data on wound dehiscence after
anterior colpotomy, the correlation between this wound closure and dehiscence is
unknown, as also the relationship between wound dehiscence and prosthetic material
exposure.The aim of the study was to assess the prevalence of anterior vaginal wall dehiscence
in women who underwent anterior vaginal wall colpotomy for pelvic organ prolapse or
stress urinary incontinence. A second purpose was to evaluate the influence of
suture materials and suture techniques on wound dehiscence, and the relationship
between prosthetic surgery and wound dehiscence.
Materials and methods
This was a multicenter, prospective study involving nine different urological and
gynecological departments of Tertiary Hospitals and 13 surgeons experienced in
urogynecology. Patients were enrolled between January 2019 and December 2019.
Inclusion criteria were naïve women for urogynecological surgery affected by
anterior vaginal wall defect or stress urinary incontinence. Exclusion criteria were
connective tissues diseases, diabetes, and peripheral vascular disease. Performed
surgical procedures were AVWR with native tissue (N-AVWR) or polypropylene mesh
(M-AVWR), and trans-obturator polypropylene in-out MUS.Wound dehiscence was considered as a complete or partial separation of opposed suture
margins within 14 days after surgery.[6-9] Sagittal, inverted T or U
colpotomy, and trimming of excessive vaginal epithelium were avoided in order to
reduce the rate of vaginal mesh exposure.
Used suture materials were Vicryl 2-0, Vicryl Rapide 2-0, Monocryl 3-0.
Suture techniques were running interlocking or interrupted aiming to make a stitch
each 5 mm along the entire length of the wound, and passing the point at a lateral
distance of 5–7 mm from the incision. Each suture was tight with 5 knots. Surgeons
performed colpotomy closure with the suture material and stitching technique usually
used.Data were collected anonymously in a database recording: the suture material;
stitching technique; surgical technique data (kind and length of incision,
procedure, and operating time); occurrence of wound dehiscence, its length and
treatment; dyspareunia; leucorrhea; vaginal discharge; and the duration of vaginal
blood spots. Complications were ranked by Clavien–Dindo scale. Follow-up was
performed daily during the hospitalization, and in outpatient clinic after 10–14, 30
days, and after 3 months.
Results
An amount of 1139 patients were enrolled. Mean age of women underwent AVWR was 66.8
y.o. (SD ± 10), while for MUS was 62.3 y.o. (SD ± 12). AVWR were 790: 89.1% N-AVWR
(704/790), and 10.9% M-AVWR (86/790). Polypropylene MUS were 349. Women with
synthetic material implantation, M-AVWR and MUS, were 435 (38.2%), while 704 (61.8%)
had native tissue repair.In all the cases, there was a vertical midline vaginal incision, with a mean length
of 1 cm for MUS, and of 4 cm for AVWR. Mean operating time for AVWR was 55 minutes
(SD ± 16), while for MUS was 19 minutes (SD ± 11). Mean blood loss for AVWR was 57
ml (SD ± 85), and for MUS 28ml (SD + 34)Table 1 reports the data
on suture materials and suture techniques according to the different anterior
vaginal wall surgical procedures.
Table 1.
Sutures and stitching techniques in different anterior vaginal wall surgical
procedures.
Sutures and stitching techniques in different anterior vaginal wall surgical
procedures.M-AVWR, mesh-anterior vaginal wall repair; MUS, middle urethral sling;
N-AVWR, native tissue anterior vaginal wall repair.
Suture materials
In overall wound closure, Vicryl was used in 53.9%, Vicryl Rapide in 37.4%, and
Monocryl in 8.7%. In women underwent N-AVWR Vicryl was used in 53.97%, Vicryl
Rapide in 33.6%, and Monocryl in 12.3%. In M-AVWR, Vicryl was the suture
material chosen in 58.1% of the cases, Vicryl Rapide in 41.9%. In MUS procedures
Vicryl was used in 52.7% of the women, Vicryl Rapide in 43.8%, and Monocryl in
3.4%.
Suture techniques
Overall running interlocking sutures were 758 (66.5%), while interrupted stitches
were 381 (33.5%). In women with N-AVWR, running interlocking was done in 674
patients (83.5%), while interrupted stitches were used in 30 (16.5%). In the
cases of M-AVWR, 35 had running interlocking (40.7%), while 51 interrupted
sutures (59.3%). In women treated with MUS for urinary incontinence, running
interlocking suturing technique was performed in 49 patients (14%), while
interrupted stitches were utilized in 300 (86%).
Wound dehiscence
Overall wound dehiscence prevalence was 0.9% (10/1139). Wound dehiscence length
ranged from 0.8 to 2.5 cm in AVWR, while in MUS were all lower than 1 cm. Wound
dehiscence rate of 0.6% (5/790) was documented in AVWR: 0.3% (2/704) in N-AVWR,
and 3.5% (3/86) in M-AVWR. Among women underwent MUS, 1.4% (5/349) showed wound
dehiscence. In patients who underwent prosthetic surgery, the overall dehiscence
prevalence was 1.8% (8/435). A statistically significant higher rate of wound
dehiscence was found in women with implanted prosthetic materials (chi-square
test p = 0.0062, with Yates correction
p = 0.016). Table 2 reports the overall prevalence
of wound dehiscence according to materials and suture techniques; while Table 3 reports the
prevalence of wound dehiscence according to the surgical procedures.
Table 2.
Overall prevalence of wound dehiscence according to materials and suture
technique.
Vicryl
Vicryl Rapide
Monocryl
Interrupted
Overall, n
265
116
–
Dehiscence,
1.5% (4/265)
1.7% (2/116)
–
Interlocking running
Overall, n
350
309
99
Dehiscence
0.28% (1/350)
0.64% (2/309)
1.01% (1/99)
Table 3.
Prevalence of wound dehiscence of non-prosthetic (N-AVWS), prosthetic
surgery (M-AVWS and MUS), M-AVWS, and MUS.
Overall prevalence of wound dehiscence according to materials and suture
technique.Prevalence of wound dehiscence of non-prosthetic (N-AVWS), prosthetic
surgery (M-AVWS and MUS), M-AVWS, and MUS.M-AVWR, mesh-anterior vaginal wall repair; MUS, middle urethral
sling; N-AVWR, native tissue anterior vaginal wall repair.
Comparing data
We found wound dehiscence in three running interlocking sutures (1 Vicryl, 1
Monocryl, and 1 Vicryl Rapide), and seven interrupted sutures (4 Vicryl, 1
Monocryl, 2 Vicryl Rapide). Overall, using chi-square with Yates test
correction, we did not found significant correlation between wound dehiscence
and the kind of stitching technique (p = 0.058), nor with the
used material (p = 0.66).Overall, all wound dehiscence with underlying prosthetic material were surgically
closed, while the others were conservatively managed. According to Clavien–Dindo
scale we had three cases of Grade III complications: two were III a
(percutaneous drainage of hematoma) and one was III b (surgical
transvaginal drainage of hematoma and blood transfusion). At 3 months, none of
the patients had wound healing complication.Outcomes of surgery at 3 months follow-up did not differ comparing the suture
material and/or the suture technique.
Discussion
To date, no data on wound dehiscence in women who underwent anterior vaginal wall
colpotomy for pelvic organ prolapse or stress urinary incontinence surgery has been
reported. In literature, vaginal wall dehiscence has been evaluated only in case of
vaginal cuff dehiscence after hysterectomy with a rate varying from 0% to
7.5%.[10-12]Kim et al. assessed the cuff suture method, finding that continuous
suture was superior to vaginal approach continuous locking suture. However,
continuous suture was done intracorporeal and not by vaginal route.Our research found a low overall prevalence of vaginal wall wound dehiscence
(<1%), but not negligible; therefore, the diagnosis and therapy of this
complication should not be underestimated. Fatton et al.
recognized inverted T colpotomy as a potential cause promoting vaginal wall
dehiscence. However, this latter incision was longer than those performed in our
study. Indeed, in our series vaginal wall dehiscence occurred despite short vertical
colpotomy not exceeding 4 cm, thus less invasive. Therefore, a tiny incision did not
preserve from this potential complication.Our data showed a three-fold increase of wound dehiscence rate in women with
implanted prosthetic materials, with a statistically significant difference.
Conversely, the sub-analysis comparing wound dehiscence to the materials used and
the suture method did not show any significant correlation. It was necessary to
provide evidences on the occurrence of wound dehiscence to prove the hypothesis of a
relationship between wound dehiscence and materials extrusion. Indeed, it could be
postulated that early wound complications may lead to mesh extrusion. Our data
showed that implanted patients were at higher risk of wound dehiscence, regardless
of the surgical techniques and kind of stiches. Dehiscence occurs in the early
post-operative time, usually 5–8 days following surgery, while extrusions with
concomitant wound dehiscence are never seen so early.
This is a crucial difference between these two complications. Thus, our data
evidenced a negative influence of the mesh/tape on the wound dehiscence, and that
implantation surgery was a risk factor for wound complication. In literature,
prosthetic materials are associated to extrusion of the vaginal mucosa.[4,13,15,16,17] However, our findings showed
that early wound dehiscence was correlated to synthetic materials; therefore, it is
possible that some of the erosions/extrusions have begun as a not identified early
asymptomatic wound dehiscence. An explanation of the pathophysiological mechanism is
that synthetic materials may affect wound healing, impairing the balance of the
vaginal epithelium favoring a dehiscence.Although we found no statistical difference among women underwent AVWR, a higher rate
(four times greater) of wound dehiscence was found using Monocryl suture with
interlocking technique, compared to Vicryl or Vicryl Rapide. Therefore, in case of
AVWR, we suggest the use of Vicryl/ Vicryl Rapide material to close colpotomy.
Unfortunately, we could not compare interrupted suture, and this is a limit of our
study.Among patients underwent prosthetic surgery, we did not correlate the results between
colpotomy closure by Vicryl/ Vicryl Rapide suture and Monocryl due to the low sample
size of this latter group. This was another limitation of our study. However, in
women implanted with synthetic material, we found no difference in wound dehiscence
rate between Vicryl and Vicryl Rapide suture with interrupted suture method. In
patients treated with mesh, wound dehiscence rate was higher when Vicryl was used.
The increasing trend of increase of wound dehiscence in MUS was different, showing a
higher rate in case of Vicryl rapide. These findings may suggest that Vicryl Rapide
was a more efficient material for larger incision, while Vicryl for shorter wound.
Unfortunately, a limitation was that we were not able to correlate all the suture
techniques in prosthetic patients. However, this was a real practice study design,
leading each experienced surgeon to perform their usual colpotomy closure.
Conclusion
We reported for the first time the prevalence of wound dehiscence in females who
underwent colpotomy for AVWR surgery or MUS placement for stress urinary
incontinence. Wound dehiscence occurrence was low, but non negligible. We found that
this complication was poorly associated to the suture methods and materials, while
prosthetic material represented a risk factor for wound healing.
Authors: M D Blikkendaal; A R H Twijnstra; S C L Pacquee; J P T Rhemrev; M J G H Smeets; C D de Kroon; F W Jansen Journal: Gynecol Surg Date: 2012-05-03